Director/Senior Director, Global Market Access
TSP, a Syneos Health company, New York, NY, United States
Position Overview
Global Market Access Director/Senior Director for a global biopharmaceutical company specializing in severe orphan diseases. The role reports to the Global Head of Market Access.
Location East coast required – hybrid WFH/WFO. Office based in Bedminster, NJ.
Key Responsibilities
Define and execute the US pricing and reimbursement strategy, ensuring optimal coverage and access across US payers.
Develop and lead US payer value positioning and negotiations, leveraging strong knowledge of US reimbursement pathways.
Serve as the US market access strategic lead for launch, working cross‑functionally with Medical, Regulatory, and Commercial teams.
Develop and steer the US global pricing and reimbursement strategy for an oral liquid, ensuring alignment with the global strategy.
Support and advise global and regional teams on pricing governance, access risks, and value positioning in rare diseases.
Attend and provide strategic insights to governance meetings, aiming to influence the strategic plan of an oral liquid formulation worldwide on a short and medium term.
Qualifications
Senior level, strategic market access leader with proven experience in US payer engagement and negotiations.
Experience of 8-10 years in pharma industry and/or consultancy, ideally within rare/orphan diseases.
Deep understanding of the US healthcare and reimbursement environment, with ability to conduct successful negotiations with US payers.
Strong ability to influence global P&R strategy based on US market realities.
Comfortable operating in a global, matrix organization, a mid‑size, French family‑owned company with high visibility and impact.
Compensation Base salary range: $250,000–$280,000, with an annual bonus of 20% based on experience and qualifications.
#J-18808-Ljbffr
Location East coast required – hybrid WFH/WFO. Office based in Bedminster, NJ.
Key Responsibilities
Define and execute the US pricing and reimbursement strategy, ensuring optimal coverage and access across US payers.
Develop and lead US payer value positioning and negotiations, leveraging strong knowledge of US reimbursement pathways.
Serve as the US market access strategic lead for launch, working cross‑functionally with Medical, Regulatory, and Commercial teams.
Develop and steer the US global pricing and reimbursement strategy for an oral liquid, ensuring alignment with the global strategy.
Support and advise global and regional teams on pricing governance, access risks, and value positioning in rare diseases.
Attend and provide strategic insights to governance meetings, aiming to influence the strategic plan of an oral liquid formulation worldwide on a short and medium term.
Qualifications
Senior level, strategic market access leader with proven experience in US payer engagement and negotiations.
Experience of 8-10 years in pharma industry and/or consultancy, ideally within rare/orphan diseases.
Deep understanding of the US healthcare and reimbursement environment, with ability to conduct successful negotiations with US payers.
Strong ability to influence global P&R strategy based on US market realities.
Comfortable operating in a global, matrix organization, a mid‑size, French family‑owned company with high visibility and impact.
Compensation Base salary range: $250,000–$280,000, with an annual bonus of 20% based on experience and qualifications.
#J-18808-Ljbffr